Studies Placebos and Oxytocin reduce sexual aversion

"Viagra for the woman "does not look any better than other remedies
Since mid-October, the new "Viagra for women" is available in the US, which is intended to stimulate sexual desire by the active ingredient Flibanserin. But the controversial Lustpille does not seem to work better or worse than other means. As a study by MedUni Vienna shows, the "bonding hormone" oxytocin or even a placebo can significantly improve the woman's female sex life.
Lustpille for the woman since October in the USA available
It is estimated that as many as 40 percent of European women suffer from diminished sexual drive, which is technically referred to as "hypoactive sexual desire disorder" or "HSDD" for short. The lack or non-existence of sexual desire can be permanent or recurrent, and some women feel so restricted that they seek therapeutic support.
Lustpillen for the woman no better than a placebo? (Image: Photographee.eu/fotolia.com)
Remedy should now bring the first "pleasure pill" for the woman, which was introduced under the name "Addyi" in October on the American market. But the drug, despite its nickname "Viagra for the woman" is not comparable to the little blue pills for the man, which act directly on the body and help to get an erection. The ingestion of the female pleasure pill should instead lead to mental effects, by the active ingredient flibanserin influences the messengers dopamine and serotonin and thereby stimulates the libido.

Admission authority rejects funds only twice
Because flibanserin is actually a psychotropic drug, which was originally developed by the German manufacturer Boehringer Ingelheim as a remedy for depression. But in the development of the researchers of the pharmaceutical company recognized that the substance may also increase the pleasure of women. However, several tests showed little effect and a number of side effects, so that the US Food and Drug Administration (FDA) initially refused to approve the drug twice. Only after a merger with American women's associations, the manufacturer was able to get a permit for the market launch of the pink pills in the third attempt.

Thirty women receive oxytocin nasal spray for more than eight months
Now, a recent study by the Medical University of Vienna confirms that flibanserin does not appear to have a better effect than other drugs. As reported by the university, a team led by project manager Michaela Bayerle-Eder had investigated to what extent the oxytocin, known as the "binding hormone", can also promote sexuality. For this purpose, 30 women used oxytocin nasal spray for eight months immediately prior to the sexual act, with all subjects affected by sexual dysfunction (agitation problems, orgasm problems, etc.). One control group took a nasal spray containing a placebo at the same time.

It was found that the sex life and sexual satisfaction in women significantly improved by treatment with the "loyalty hormone" oxytocin. But the effect was ultimately minimal, because the placebo group also showed significantly improved values, according to the announcement of the University of Vienna. According to project manager Michaela Bayerle-Eder, this proves how important communication with the partner is for sexual satisfaction.

"Apparently, the fact that the women dealt more intensively with their sexuality in the course of the study and talked to their partner about sex, already measurable improvements," said the internist and sexual medicine of MedUni Vienna. Therefore, it would be reasonable to conclude that decreased sexual desire is often due solely to misunderstandings in the relationship: "Often, stress in everyday life is the cause of sexual ailments rather than any chemical deficiency in women's hormonal balance." Therefore, it is recommended in sexual To seek medical help as promptly as possible in order to be able to discover the actual cause of the discomfort. (No)